U.S. Colorectal Cancer Screening Market is driven by Technological Advances
The U.S. Colorectal Cancer Screening Market encompasses various diagnostic products including colonoscopy systems, fecal immunochemical tests (FIT), stool DNA assays, and emerging blood-based biomarkers. Colonoscopy remains the gold standard for direct visualization and polyp removal, while FIT and stool DNA tests offer non-invasive, cost-effective alternatives with high sensitivity and...
0 Commenti 0 condivisioni 8 Views 0 Anteprima
Sponsorizzato